79.8 %Africans had the highest rs1799966 T allele frequency at 79.8%.
Nigeriacancer du seinpublished 2026Cancer control : journal of the Moffitt Cancer CenterPubMeddocument of 7 observations
Gold tier: mechanically validated evidence, with its primary source.
381 evidence items · page 13 / 16
79.8 %Africans had the highest rs1799966 T allele frequency at 79.8%.
Nigeriacancer du seinpublished 2026Cancer control : journal of the Moffitt Cancer CenterPubMeddocument of 7 observations
52 %For women with BMI ≥ 30, each standard deviation increase in cumulative lifetime endogenous estrogen exposure (CLEEE) was associated with 52% higher breast cancer odds in multivariable models.
Nigeriacancer du seinpublished 2026Breast cancer research and treatmentPubMeddocument of 10 observations
67 %67% of participants had stage 3 or 4 disease.
Nigeriacancer du seinpublished 2023Psycho-oncologyPubMeddocument of 9 observations
37.7 %37.7% of the respondents had average general knowledge of breast cancer.
Nigeriacancer du seinpublished 2024West African journal of medicinePubMeddocument of 7 observations
74 %260 out of 352 breast cancer patients (74%) risked financial catastrophe.
Nigeriacancer du seinpublished 2025American journal of surgeryPubMeddocument of 13 observations
86.1 %Of 577 patients with information on tumor stage, 86.1% (497) were diagnosed at stage III or IV.
Nigeriacancer du seinpublished 2018Journal of clinical oncology : official journal of the American Society of Clinical Oncoloeurope_pmcdocument of 14 observations
63 casesMalaria infection was present in 63 of 70 breast cancer patients.
Nigeriacancer du sein · paludismepublished 2022Annals of African medicinePubMeddocument of 8 observations
6.6 cmMedian tumor size was 6.6 cm (IQR 4.4,10.1).
Nigeriacancer du seinpublished 2026Psycho-oncologyPubMeddocument of 11 observations
Breast cancer remains a significant health burden globally, with high incidence and mortality rates, particularly in Nigeria.
Nigeriacancer du seinpublished 2024PloS onePubMeddocument of 2 observations
0.001 p-valueHigh breast cancer knowledge was significantly associated with early detection (p-value = 0.001).
Nigeriacancer du seinpublished 2021PloS onePubMeddocument of 6 observations
95.5 %95.5% of female artisans in Ibadan, Nigeria expressed willingness to participate in integrated HIV and breast cancer interventions.
Nigeriacancer du sein · VIH/sidapublished 2025Women's health (London, England)PubMeddocument of 7 observations
144 patientsThere were 144 breast cancer patients in the institutional database during 2013–2015.
Nigeriacancer du seinobserved 2013-2015published 2023West African journal of medicinePubMeddocument of 8 observations
3 per_10Breast cancer constituted approximately three in ten cancer cases in females at the University of Ilorin Teaching Hospital from January 2011 to December 2020.
Nigeriacancer du seinobserved January 2011 to December 2020published 2023Nigerian journal of clinical practicePubMeddocument of 8 observations
92 %Of 274 health care professionals, 253 (92%) believed that breast cancer guidelines contribute to better patient outcomes.
Nigeriacancer du seinpublished 2025JAMA network openPubMeddocument of 8 observations
48 %Lack of money was reported as a barrier to breast cancer screening by 48.0% of participants.
Nigeriacancer du seinpublished 2023African health sciencesPubMeddocument of 4 observations
86.36 %Africans showed the highest frequency of the rs799917 A allele at 86.36%.
Nigeriacancer du seinpublished 2026Cancer control : journal of the Moffitt Cancer CenterPubMeddocument of 7 observations
7.58 %Middle-aged individuals had 7.58% knowledge about smoking as a breast cancer risk factor.
Nigeriacancer du seinpublished 2024JCO global oncologyPubMeddocument of 12 observations
13.16 yearsPost-menopausal women with breast cancer had significantly lower mean age at menarche (13.16 ± 0.87 years) compared to controls (14.14 ± 1.60 years), with P < 0.001.
Nigeriacancer du seinpublished 2021Nigerian journal of clinical practicePubMeddocument of 6 observations
84 %84% of breast cancer patients in the cohort presented with stage III or IV disease.
Nigeriacancer du seinobserved May 2009–January 2019published 2021CancerPubMeddocument of 7 observations
22.1 %Progesterone receptor positivity was 22.1%.
Nigeriacancer du seinpublished 2024West African journal of medicinePubMeddocument of 13 observations
4.06 scoreThe average breast cancer knowledge score of the participants was 4.06 (40.57%).
Nigeriacancer du seinpublished 2023African journal of reproductive healthPubMeddocument of 10 observations
3 %The hazard of progressing from early to locally advanced breast cancer was 3% in the first 30 days.
Nigeriacancer du seinobserved June 2017 to May 2018published 2020BMC public healthPubMeddocument of 9 observations
13.5 %Practice of preventive behaviours increased by 13.5% at one month relative to baseline in three randomly-selected schools in Southeast Nigeria.
Nigeriacancer du seinpublished 2025Journal of health, population, and nutritionPubMeddocument of 6 observations
Breast cancer patients have a higher prevalence of dyslipidaemia and cardiovascular risk than the normal population.
Nigeriacancer du sein · dyslipidemia · maladies cardiovasculairespublished 2024Journal of the American Nutrition AssociationPubMeddocument of 2 observations
1 %Among all cases, 1.0% carried a loss-of-function mutation in PALB2.
Nigeriacancer du seinpublished 2018Journal of clinical oncology : official journal of the American Society of Clinical Oncoloeurope_pmcdocument of 14 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.